WARNING: We do not support Internet Explorer. It is not secure and will not work correctly. Please come back using a newer web browser.
Read the latest articles about CLSI and laboratory standards in the official CLSI Blog. Browse our most recent blog articles below.
We spoke with Ted Schutzbank, PhD D(ABMM), Scientific Affairs Manager of Diagnostics at Meridian Bioscience about the importance of standardization in molecular diagnostics and the new testing methods available for COVID-19.
Read More
Medical Laboratory Professionals Week (MLPW) provides the profession with a unique opportunity to increase public understanding of and appreciation for clinical laboratory personnel.
Read More
Antimicrobial resistance is one of the most serious global health threats in the world. In the United States, there are 2.8 million antibiotic-resistant infections each year that cause more than 35,000 deaths. Some experts fear that the real number is much higher. The superbugs that cause these infections thrive in hospitals and medical facilities, putting all patients at risk. The patients at greatest risk from superbugs are the ones who are already more vulnerable to illness from viral lung infections like influenza, severe acute respiratory syndrome (SARS), and COVID-19.
Read More
As of April 8, 2020, the global health threat now known as coronavirus disease-2019 (COVID-19) had infected more than 1.3 million people in over 200 countries and caused more than 79,000 deaths [1]. According to the “Operational Planning Guidelines to Support Country Preparedness and Response” developed by the World Health Organization (WHO), a coordinated global response plan that primarily involves prevention of human-to-human transmission of the virus, caring and monitoring of infected patients, and rapid diagnosis of the disease followed by effective infection control measures is required to control the COVID-19 pandemic [2].
Read More
While laboratory workers are always vigilant against laboratory-acquired infections, uncertainty has arisen in the medical laboratory community about the most effective way to protect against COVID-19. The United States Department of Labor Occupational Safety and Health Administration (OSHA) provides guidelines for safe COVID-19 specimen processing, as well as information about proper personal protective equipment (PPE) for laboratory workers.
Read More
The bipartisan bill, Verifying Accurate Leading-edge IVCT Development Act (VALID), was introduced to Congress on March 5, 2020. This legislative effort, if enacted, will overhaul the regulatory oversight of in vitro diagnostics (IVDs) in the United States and create a single system for regulation of LDTs and manufacturers’ IVCTs.
Read More
Taking blood samples from children can be difficult for the phlebotomist. Ensuring safety while accounting for a pediatric patient’s emotional and physical well-being is of the utmost importance.
Read More
Measurement procedure comparison is one of the most common techniques used by both manufacturers and medical laboratorians to estimate the bias of an in vitro diagnostic (IVD) measurement procedure relative to a comparator.
Read More
At the invitation of US Centers for Disease Control (CDC), CLSI’s Global Health Partnerships (GHP) visited Tanzania, one of the first countries with which GHP partnered, in 2005. This was to be the first of many visits and a long-term partnership.
Read More
Interference screening in clinical chemistry is conducted by paired-difference testing: samples with and without the interferent are measured, and the measurand concentration difference is determined.
Read More